Preclinical<i> In Vitro</i> and<i> In Vivo</i> Evaluation of [<sup>18</sup>F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer

<div>Immunofluorescent staining of HT-29 cells; left: DAPI, middle: FITC, right: merge. Upper row: mouse isotype control, lower row: anti-human A<sub>3</sub>AR staining.</div>

Contrast Media & Molecular Imaging

fig2

Figure 2

Figure 2: Preclinical<i> In Vitro</i> and<i> In Vivo</i> Evaluation of [<sup>18</sup>F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer 

Figure 2 | Preclinical In Vitro and In Vivo Evaluation of [18F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer 